News By Tag
News By Place
Follow on Google News
Journey Medical Corp Announces New Journey with the Experts Video Featuring Michael McKelvey, MD
Dr. McKelvey discusses cysts, a very common skin condition in the United States
A cyst is an abnormal, usually noncancerous growth filled with liquid or a semisolid substance, sometimes causing pain. Cysts are very common and may form anywhere in the body. To view the Journey with the Experts video featuring Dr. McKelvey, please visit https://vimeo.com/
About Journey with the Experts
Journey with the Experts is an educational initiative supported by Journey Medical Corporation, the medical dermatology company. The initiative is designed to educate the general public on common medical dermatology skin disorders and explain how these conditions can be treated at local dermatology practices.
The information, including, without limitation, topics, presentations, discussions, content, descriptions or any other material contained herein is for informational purposes only. None of the material herein is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified HCP with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay seeking it because of something you have heard, observed, or inferred herein. Any reliance is strictly prohibited.
About Journey Medical Corporation
Journey Medical is focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. The company currently markets seven products that help treat and heal common skin conditions. The Journey Medical team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey Medical is located in Scottsdale, Arizona and is a partner company of Fortress Biotech, Inc. (NASDAQ:FBIO)
About Michael McKelvey, MD
A native of Southeast Ohio, Dr. McKelvey received his undergraduate degree from Miami University and completed medical school at The Ohio State University College of Medicine, graduating with honors at all levels of his education. Following medical school, he completed his internship at Riverside Methodist Hospital and then returned to The Ohio State University Medical Center for residency training in dermatology.
Dr. McKelvey prides himself on being a well-rounded physician, enjoying the medical, surgical and cosmetic components of dermatology. He also enjoys teaching and is active in the education of resident physicians. He currently lectures at The Ohio State University and is a preceptor for clinics at the VA Medical Center. Dr. McKelvey is a past President of the Central Ohio Dermatological Society. For additional information about Dr. McKelvey, please visit https://dermatologycolumbus.com/
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. As used below and throughout this press release, the words "we", "us" and "our" may refer to Fortress individually, a partner company individually, or Fortress together with one or more partner companies, as dictated by context. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships;
Jaclyn Jaffe and Bill Begien
Fortress Biotech, Inc.
Page Updated Last on: Sep 17, 2021